27-34 Of note, several trials in the PIONEER program used two estimands to further distinguish their analyses: 1) a treatment-policy estimand, which used data collected at the end of the study period (e.g., week 26 or 52) in the analysis regardless of treatment discontinuation or use of rescue medication
Protocol Quick-Reference Lean mass preservation during GLP-1 agonist weight loss therapy Dosing Amount 200-400 mg Frequency Subcutaneous injection (dosing interval not publicly specified) Duration 26-week weight-loss phase followed by 26-week maintenance Administration Route SC Schedule Periodic subcutaneous injection (interval not disclosed) Timing Administered in combination with semaglutide 2.4 mg SC weekly in the COURAGE trial
Answer: Zepbound Exercise 2 Correct the Sentence Wegovy contains tirzepatide
Not for those with heart conditions or anxiety
Blum says, "Microdosing a GLP-1 means you're taking a dose that's lower than the lowest granular dose designated for weight loss." A therapeutic dose for weight loss using a semaglutide medication (Wegovy or Ozempic) is typically 2.4 mg, and the therapeutic dose for a tirzepatide medication (Zepbound and Mounjaro) is around 15 mg
You may also want to explore other alternatives to Wegovy or Ozempic with your healthcare provider
